Mycotic Aneurysm

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 6864 Experts worldwide ranked by ideXlab platform

Kentaro Iwata - One of the best experts on this subject based on the ideXlab platform.

  • Mycotic Aneurysm caused by Edwardsiella tarda successfully treated with stenting and suppressive antibiotic therapy: a case report and systematic review
    Annals of clinical microbiology and antimicrobials, 2018
    Co-Authors: Kei Ebisawa, Sho Nishimura, Shungo Yamamoto, Goh Ohji, Kentaro Iwata
    Abstract:

    Mycotic Aneurysm is an uncommon disease which could be fatal without appropriate treatment. Although standard therapy for Mycotic Aneurysms consists of resection of the infected aorta and in situ graft replacement, some treat with endovascular stent-grafting because patients may not tolerate graft replacement due to underlying diseases. There are 6 more reported cases of Mycotic Aneurysm caused by Edwardsiella tarda. With the exception of our case, all underwent resection and debridement of the infected aorta or vascular prosthesis. Herein we report the first case ever of Mycotic Aneurysm caused by E. tarda, successfully treated with stenting and suppressive antibiotic therapy without resection of the infected aorta. A 65-year-old Japanese woman with cirrhosis and hepatocellular carcinoma complained of fatigue. Her work up revealed a ruptured Aneurysm of the descending aorta. She went through endovascular stent-graft placement. Edwardsiella tarda grew from blood cultures, which led to the diagnosis of Mycotic Aneurysm. Edwardsiella tarda is a Gram negative bacillus which rarely causes infections in humans. In the case of bacteremia, its mortality is reported to be very high and all reported cases with Mycotic Aneurysm caused by E. tarda ended up with resection of the infected aorta. Our case shows that in the case of Mycotic Aneurysm caused by E. tarda, endovascular stent-graft placement could be an alternative to in situ graft replacement.

  • Mycotic Aneurysm caused by Edwardsiella tarda successfully treated with stenting and suppressive antibiotic therapy: a case report and systematic review
    BMC, 2018
    Co-Authors: Kei Furui Ebisawa, Sho Nishimura, Shungo Yamamoto, Goh Ohji, Kentaro Iwata
    Abstract:

    Abstract Background Mycotic Aneurysm is an uncommon disease which could be fatal without appropriate treatment. Although standard therapy for Mycotic Aneurysms consists of resection of the infected aorta and in situ graft replacement, some treat with endovascular stent-grafting because patients may not tolerate graft replacement due to underlying diseases. There are 6 more reported cases of Mycotic Aneurysm caused by Edwardsiella tarda. With the exception of our case, all underwent resection and debridement of the infected aorta or vascular prosthesis. Herein we report the first case ever of Mycotic Aneurysm caused by E. tarda, successfully treated with stenting and suppressive antibiotic therapy without resection of the infected aorta. Case presentation A 65-year-old Japanese woman with cirrhosis and hepatocellular carcinoma complained of fatigue. Her work up revealed a ruptured Aneurysm of the descending aorta. She went through endovascular stent-graft placement. Edwardsiella tarda grew from blood cultures, which led to the diagnosis of Mycotic Aneurysm. Edwardsiella tarda is a Gram negative bacillus which rarely causes infections in humans. In the case of bacteremia, its mortality is reported to be very high and all reported cases with Mycotic Aneurysm caused by E. tarda ended up with resection of the infected aorta. Conclusion Our case shows that in the case of Mycotic Aneurysm caused by E. tarda, endovascular stent-graft placement could be an alternative to in situ graft replacement

James E. Silberzweig - One of the best experts on this subject based on the ideXlab platform.

Matthias Loebe - One of the best experts on this subject based on the ideXlab platform.

  • superior mesenteric artery Mycotic Aneurysm in patients with left ventricular assist device support and intravenous drug abuse
    Artificial Organs, 2011
    Co-Authors: T Motomura, Brian A Bruckner, Joel Leonbecerril, Javier Ayalaanayal, Beatriz De Rienzomadero, Jean Bismuth, R R Bunge, Suellen Irwin, Matthias Loebe
    Abstract:

    : Mycotic Aneurysm of the superior mesenteric artery (SMA) is one of the complications associated with infective endocarditis. However, there are no previous case reports in the literature describing Mycotic SMA Aneurysm after left ventricular assist device (LVAD) implantation. We describe the case of a 31-year-old male diagnosed with congestive heart failure due to nonischemic dilated cardiomyopathy who underwent LVAD implantation for bridge to heart transplantation. The postoperative course was uneventful, and the patient was maintained on anticoagulation and antiplatelet therapy. There were no signs of pump failure or device-related infections. However, 7 months post-LVAD support, the patient complained of abdominal symptoms (nausea and vomiting) with low-grade fever. Computed tomography identified an Aneurysmal change of the SMA (2.2 × 1.8 cm). There was no evidence of thrombus or septic vegetation inside the heart. Aneurysm and segmental small bowel resection was performed. Pathological study revealed typical findings of Mycotic Aneurysm with significant infiltration of inflammatory cells. The patient, however, expired due to concurrent brain hemorrhage. Postmortem study indicated no sign of pump thrombus or septic emboli inside the pump or inflow/outflow conduit. This case report presents a rare Mycotic Aneurysm that developed in the SMA after chronic LVAD support.

Kei Ebisawa - One of the best experts on this subject based on the ideXlab platform.

  • Mycotic Aneurysm caused by Edwardsiella tarda successfully treated with stenting and suppressive antibiotic therapy: a case report and systematic review
    Annals of clinical microbiology and antimicrobials, 2018
    Co-Authors: Kei Ebisawa, Sho Nishimura, Shungo Yamamoto, Goh Ohji, Kentaro Iwata
    Abstract:

    Mycotic Aneurysm is an uncommon disease which could be fatal without appropriate treatment. Although standard therapy for Mycotic Aneurysms consists of resection of the infected aorta and in situ graft replacement, some treat with endovascular stent-grafting because patients may not tolerate graft replacement due to underlying diseases. There are 6 more reported cases of Mycotic Aneurysm caused by Edwardsiella tarda. With the exception of our case, all underwent resection and debridement of the infected aorta or vascular prosthesis. Herein we report the first case ever of Mycotic Aneurysm caused by E. tarda, successfully treated with stenting and suppressive antibiotic therapy without resection of the infected aorta. A 65-year-old Japanese woman with cirrhosis and hepatocellular carcinoma complained of fatigue. Her work up revealed a ruptured Aneurysm of the descending aorta. She went through endovascular stent-graft placement. Edwardsiella tarda grew from blood cultures, which led to the diagnosis of Mycotic Aneurysm. Edwardsiella tarda is a Gram negative bacillus which rarely causes infections in humans. In the case of bacteremia, its mortality is reported to be very high and all reported cases with Mycotic Aneurysm caused by E. tarda ended up with resection of the infected aorta. Our case shows that in the case of Mycotic Aneurysm caused by E. tarda, endovascular stent-graft placement could be an alternative to in situ graft replacement.

Irfan Sabah - One of the best experts on this subject based on the ideXlab platform.